DEXTRIFERRON: 11 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
11
Total FAERS Reports
1 (9.1%)
Deaths Reported
10
Hospitalizations
11
As Primary/Secondary Suspect
First Report: 201707 · Latest Report: 201707
What Are the Most Common DEXTRIFERRON Side Effects?
#1 Most Reported
Pulmonary hypertension
10 reports (90.9%)
#2 Most Reported
Upper gastrointestinal haemorrhage
9 reports (81.8%)
#3 Most Reported
Tricuspid valve incompetence
9 reports (81.8%)
All DEXTRIFERRON Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Pulmonary hypertension | 10 | 90.9% | 1 | 9 |
| Blood pressure abnormal | 9 | 81.8% | 0 | 9 |
| Cardiac failure | 9 | 81.8% | 0 | 9 |
| Cyanosis | 9 | 81.8% | 0 | 9 |
| Ejection fraction decreased | 9 | 81.8% | 0 | 9 |
| Jugular vein distension | 9 | 81.8% | 0 | 9 |
| Left ventricular hypertrophy | 9 | 81.8% | 0 | 9 |
| Myocardial infarction | 9 | 81.8% | 0 | 9 |
| Myocardial ischaemia | 9 | 81.8% | 0 | 9 |
| Nephrogenic anaemia | 9 | 81.8% | 0 | 9 |
| Oedema | 9 | 81.8% | 0 | 9 |
| Peripheral swelling | 9 | 81.8% | 0 | 9 |
| Respiratory failure | 9 | 81.8% | 0 | 9 |
| Respiratory tract infection viral | 9 | 81.8% | 0 | 9 |
| Tricuspid valve incompetence | 9 | 81.8% | 0 | 9 |
| Upper gastrointestinal haemorrhage | 9 | 81.8% | 0 | 9 |
| Dependence on oxygen therapy | 7 | 63.6% | 0 | 7 |
| Dyspnoea | 5 | 45.5% | 0 | 5 |
| Dyspnoea exertional | 5 | 45.5% | 0 | 5 |
Who Reports DEXTRIFERRON Side Effects? Age & Gender Data
Gender: 0.0% female, 100.0% male. Average age: 22.0 years. Most reports from: SI. View detailed demographics →
Is DEXTRIFERRON Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2017 | 9 | 0 | 9 |
What Is DEXTRIFERRON Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 8 |
Official FDA Label for DEXTRIFERRON
Official prescribing information from the FDA-approved drug label.